[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100452314":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":17,"locations":24,"responsibleParty":45,"collaborators":10,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":10,"eligibilityCriteria":53,"healthyVolunteers":49,"sex":54,"minAge":55,"maxAge":10,"enrollmentInfo":56,"targetDuration":10,"studyType":59,"phases":10,"briefSummary":60,"conditions":61,"keywords":63,"overallStatus":26,"whyStopped":10,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"Can-Am HIFU Inc.","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Aquablation",null,[12],"Procedure: Aquablation",[14],{"type":15,"name":9,"description":9,"armGroupLabels":16,"otherNames":10},"PROCEDURE",[9],[18],{"name":19,"role":20,"phone":21,"phoneExt":22,"email":23},"Dean Elterman","CONTACT","4166035800","5033","dean.elterman@uhn.ca",[25],{"facility":19,"status":26,"city":27,"state":28,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"RECRUITING","Toronto","Ontario","M5T 2S8","Canada","CA",{"type":33,"coordinates":34},"Point",[35,36],-79.39864,43.70643,{"lat":36,"lon":35},[39,40,43],{"name":19,"role":20,"phone":21,"phoneExt":22,"email":23},{"name":41,"role":20,"phone":21,"phoneExt":42,"email":23},"Iris Chan","Elterman",{"name":19,"role":44,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"type":44,"investigatorFullName":19,"investigatorTitle":46,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Urologist","100452314","aquablation-in-benign-prostatic-hyperplasia-in-canada-100452314",false,"NCT05169892","Aquablation in Benign Prostatic Hyperplasia in Canada","Canadian Cohort of Aquablation, a Robotically Executed, Surgeon-guided, High-pressure Water Jet Ablation Therapy for Endoscopic Resection of Prostate Tissue, in Benign Prostatic Hyperplasia (BPH).","Inclusion Criteria:\n\n* Primary diagnosis of Benign Prostate Hypertrophy (BPH)\n* Male subjects of ≥ 18 years of age\n* Candidate for Aquablation therapy as per clinical decision of Investigator\n* Willing and able to accurately complete questionnaires\n* Willing and able to provide signed and dated informed consent\n\nExclusion Criteria:\n\n* Characteristics indicating a poor compliance with study protocol requirements.\n* Disease or other health condition that is not suitable for this study.\n* Unable or unwilling to provide signed informed consent.","MALE","18 Years",{"count":57,"type":58},25,"ESTIMATED","OBSERVATIONAL","To document the clinical outcome of Aquablation therapy for BPH patient in Canadian cohort.",[62],"Urologic Diseases",[64],"benigh prostate hypertrophy","2021-12-09",{"date":67,"type":68},"2021-12-27","ACTUAL",{"date":70,"type":68},"2019-10-09",{"date":72,"type":58},"2026-12-31",{"name":5,"class":6},1]